Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
NYS Entity Status
NYS Filing Date
AUGUST 22, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - CROSS VENTURE SERVICES LLC
AROUND THE WEB
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Millions Meant for Rail Tunnel Subsidize Ferry Rides for a Few
By PATRICK McGEEHAN - Thursday Jul 6, 2017
After canceling a Hudson River train tunnel, Gov. Chris Christie diverted some of the funding to a lightly used Seastreak service to Jersey City and Hoboken.
- North Korea Accuses U.S. of ‘Mugging’ Its Diplomats in New York
By CHOE SANG-HUN - Sunday Jun 18, 2017
Officials returning from a United Nations conference were about to board a plane when federal agents seized a package they were carrying.
- NY subway tiles with Confederate flag look to be altered
By TOM HAYS, Associated Press - Friday Aug 18, 2017
NEW YORK (AP) — Transit officials have decided to alter subway station tiles that have a cross-like design similar to that of the Confederate flag.The Metropolitan Transportation Authority is modifying the tiles at the 40th Street entrance to the Times Square subway stop to avoid any confusion about their meaning, MTA spokesman Kevin Ortiz said in a statement."These are not confederate flags" Ortiz said. The red, white and blue tiles installed decades ago are "based on geometric forms that represent the 'Crossroads of the World,'" he added.The decision comes in the wake of the deadly rally over a Robert E.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]